|
US3887699A
(en)
|
1969-03-24 |
1975-06-03 |
Seymour Yolles |
Biodegradable polymeric article for dispensing drugs
|
|
US3854480A
(en)
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
PH19942A
(en)
|
1980-11-18 |
1986-08-14 |
Sintex Inc |
Microencapsulation of water soluble polypeptides
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
DE3218121A1
(de)
|
1982-05-14 |
1983-11-17 |
Leskovar, Peter, Dr.-Ing., 8000 München |
Arzneimittel zur tumorbehandlung
|
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US6565841B1
(en)
|
1991-03-15 |
2003-05-20 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
|
US5407686A
(en)
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
|
WO1993015722A1
(en)
|
1992-02-07 |
1993-08-19 |
Syntex (Usa) Inc. |
Controlled delivery of pharmaceuticals from preformed porous microparticles
|
|
WO1994012158A1
(en)
|
1992-12-02 |
1994-06-09 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release growth hormone containing microspheres
|
|
EP0707650B1
(en)
|
1993-06-21 |
2003-05-21 |
Genentech, Inc. |
Process for producing human relaxin
|
|
US6011007A
(en)
|
1993-09-17 |
2000-01-04 |
Novo Nordisk A/S |
Acylated insulin
|
|
CZ287945B6
(cs)
|
1993-09-17 |
2001-03-14 |
Novo Nordisk A/S |
Inzulinový derivát a farmaceutický prostředek s jeho obsahem pro léčení diabetu
|
|
US6869930B1
(en)
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
|
US6372716B1
(en)
|
1994-04-26 |
2002-04-16 |
Genetics Institute, Inc. |
Formulations for factor IX
|
|
DK0779806T3
(da)
|
1994-09-09 |
2000-11-27 |
Takeda Chemical Industries Ltd |
Præparat til forsinket frigivelse indeholdende et metalsalt af et peptid
|
|
ATE212545T1
(de)
|
1995-03-28 |
2002-02-15 |
Fidia Advanced Biopolymers Srl |
Nanosphären mit einem biokompatiblen polysaccharid
|
|
US6184201B1
(en)
|
1995-04-14 |
2001-02-06 |
Nps Allelix Corp. |
Intestinotrophic glucagon-like peptide-2 analogs
|
|
TW457240B
(en)
|
1995-04-20 |
2001-10-01 |
Janssen Pharmaceutica Nv |
Novel triazolones as apolipoprotein-B synthesis inhibitors
|
|
US5811395A
(en)
|
1995-06-07 |
1998-09-22 |
Medical University Of South Carolina |
Relaxin analogs and derivatives methods and uses thereof
|
|
NZ310644A
(en)
|
1995-06-07 |
1999-08-30 |
Alkermes Inc |
Composition for sustained release of human growth hormone
|
|
US5911997A
(en)
|
1995-06-07 |
1999-06-15 |
Connetics Corporation |
Relaxin-like factor and methods and uses thereof
|
|
ZA965368B
(en)
|
1995-07-14 |
1997-01-14 |
Novo Nordisk As |
A pharmaceutical formulation
|
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
|
US5736152A
(en)
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
|
US5612051A
(en)
|
1995-11-17 |
1997-03-18 |
Yue; Samuel K. |
Method of treating involuntary muscle dysfunction with relaxin hormone
|
|
US5866538A
(en)
|
1996-06-20 |
1999-02-02 |
Novo Nordisk A/S |
Insulin preparations containing NaCl
|
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6444641B1
(en)
|
1997-10-24 |
2002-09-03 |
Eli Lilly Company |
Fatty acid-acylated insulin analogs
|
|
ZA989744B
(en)
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
|
DE19822820A1
(de)
|
1998-05-20 |
1999-11-25 |
Biotechnolog Forschung Gmbh |
Pharmazeutisches Präparat zur Wundbehandlung
|
|
US6566329B1
(en)
|
1999-06-28 |
2003-05-20 |
Novo Nordisk A/S |
Freeze-dried preparation of human growth hormone
|
|
JP2004535401A
(ja)
|
2001-05-21 |
2004-11-25 |
ネクター セラピューティックス |
化学的に改変されたインスリンの肺投与
|
|
EP1572720A4
(en)
|
2002-05-24 |
2008-12-24 |
Nps Allelix Corp |
PROCESS FOR THE ENZYMATIC PRODUCTION OF GLP-2 (1-34) AND GLP-2 (1-33) PEPTIDES
|
|
AU2003239478A1
(en)
*
|
2002-06-04 |
2003-12-22 |
Eli Lilly And Company |
Modified glucagon-like peptide-1 analogs
|
|
US20050176108A1
(en)
|
2003-03-13 |
2005-08-11 |
Young-Min Kim |
Physiologically active polypeptide conjugate having prolonged in vivo half-life
|
|
WO2004100997A2
(en)
|
2003-05-12 |
2004-11-25 |
Affymax, Inc. |
Spacer moiety for poly(ethylene glycol) -modified peptides
|
|
US20060183667A1
(en)
|
2003-07-11 |
2006-08-17 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
|
KR101241862B1
(ko)
|
2003-09-19 |
2013-03-13 |
노보 노르디스크 에이/에스 |
신규 ｇｌｐ-1 유도체
|
|
WO2005118620A2
(en)
|
2004-05-27 |
2005-12-15 |
New York University |
Methods for preparing internally constraied peptides and peptidomimetics
|
|
WO2006066258A2
(en)
|
2004-12-17 |
2006-06-22 |
Neose Technologies, Inc. |
Lipoconjugation of peptides
|
|
TWI372629B
(en)
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
DE602006020123D1
(de)
|
2005-05-04 |
2011-03-31 |
Zealand Pharma As |
Glucagon-like-peptide-2- (glp-2-) analoga
|
|
WO2007067828A2
(en)
|
2005-10-24 |
2007-06-14 |
Centocor, Inc. |
Glp-2 mimetibodies, polypeptides, compositions, methods and uses
|
|
CN101389648B
(zh)
|
2006-02-22 |
2013-07-17 |
默沙东公司 |
肽胃泌酸调节素衍生物
|
|
US20080305519A1
(en)
|
2006-02-23 |
2008-12-11 |
Qing Lin |
Biochemical method for specific protein labeling
|
|
KR20080113226A
(ko)
|
2006-03-16 |
2008-12-29 |
더 스크립스 리서치 인스티튜트 |
비천연 아미노산 페닐셀레노시스테인을 함유하는 단백질의 유전자적으로 프로그램된 발현
|
|
KR20090005329A
(ko)
|
2006-03-20 |
2009-01-13 |
머크 앤드 캄파니 인코포레이티드 |
뉴로메딘 ｕ 수용체 효능제 및 이의 용도
|
|
WO2007109354A2
(en)
|
2006-03-21 |
2007-09-27 |
Amylin Pharmaceuticals, Inc. |
Peptide-peptidase inhibitor conjugates and methods of using same
|
|
ES2495741T3
(es)
|
2006-04-20 |
2014-09-17 |
Amgen, Inc |
Compuestos de GLP-1
|
|
AU2007267833B2
(en)
|
2006-05-26 |
2012-07-26 |
Amylin Pharmaceuticals, Llc |
Composition and methods for treatment of congestive heart failure
|
|
WO2008028117A2
(en)
|
2006-08-31 |
2008-03-06 |
Centocor, Inc. |
Glp-2 mimetibodies, polypeptides, compositions, methods and uses
|
|
EP2069502B1
(en)
|
2006-09-27 |
2014-02-26 |
Novo Nordisk A/S |
Method for making maturated insulin polypeptides
|
|
KR20090091145A
(ko)
|
2006-10-27 |
2009-08-26 |
웨이-치앙 션 |
지질화된 인터페론 및 이의 용도
|
|
US7981998B2
(en)
|
2006-12-14 |
2011-07-19 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
|
CN105061577A
(zh)
|
2006-12-14 |
2015-11-18 |
爱勒让治疗公司 |
双巯基大环化系统
|
|
AU2008216265B2
(en)
|
2007-02-15 |
2014-04-03 |
Indiana University Research And Technology Corporation |
Glucagon/GLP-1 receptor co-agonists
|
|
ES2398310T3
(es)
|
2007-02-23 |
2013-03-15 |
Aileron Therapeutics, Inc. |
Péptidos macrocíclicos unidos a triazol
|
|
US8420598B2
(en)
|
2007-04-20 |
2013-04-16 |
B & L Delipharm Corp. |
Mono modified exendin with polyethylene glycol or its derivatives and uses thereof
|
|
AU2008266753A1
(en)
|
2007-06-20 |
2008-12-24 |
Istituto Di Recerche Di Biologia Molecolare P. Angeletti S.P.A. |
ApoA-1 peptide mimetics
|
|
KR20100126361A
(ko)
|
2008-02-08 |
2010-12-01 |
에일러론 테라퓨틱스 인코포레이티드 |
치료용 펩티드유사 거대고리
|
|
WO2009126292A2
(en)
|
2008-04-08 |
2009-10-15 |
Aileron Therapeutics, Inc. |
Biologically active peptidomimetic macrocycles
|
|
US20110144303A1
(en)
|
2008-04-08 |
2011-06-16 |
Aileron Therapeutics, Inc. |
Biologically Active Peptidomimetic Macrocycles
|
|
DK2300035T3
(en)
|
2008-06-17 |
2015-11-16 |
Univ Indiana Res & Tech Corp |
Mixed GIP-based agonists for the treatment of metabolic diseases and obesity
|
|
US8586707B2
(en)
|
2008-09-16 |
2013-11-19 |
The Research Foundation Of State University Of New York |
Stapled peptides and method of synthesis
|
|
ES2666458T3
(es)
|
2008-09-22 |
2018-05-04 |
Aileron Therapeutics, Inc. |
Macrociclos peptidomiméticos
|
|
CN102203126A
(zh)
|
2008-09-22 |
2011-09-28 |
爱勒让治疗公司 |
用于制备纯化的多肽组合物的方法
|
|
CN102884074A
(zh)
|
2008-09-22 |
2013-01-16 |
爱勒让治疗公司 |
拟肽大环化合物
|
|
EP2352507A4
(en)
|
2008-11-24 |
2012-04-25 |
Aileron Therapeutics Inc |
PEPTIDOMIMETIC MACROCYCLES WITH IMPROVED PROPERTIES
|
|
WO2010083347A2
(en)
|
2009-01-14 |
2010-07-22 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
CA2748314C
(en)
|
2009-02-03 |
2018-10-02 |
Amunix Operating Inc. |
Extended recombinant polypeptides and compositions comprising same
|
|
WO2010096052A1
(en)
|
2009-02-19 |
2010-08-26 |
Merck Sharp & Dohme Corp. |
Oxyntomodulin analogs
|
|
AP3329A
(en)
|
2009-07-13 |
2015-06-30 |
Zealand Pharma As |
Acylated glucagon analogues
|
|
MX2012003939A
(es)
|
2009-09-30 |
2012-07-30 |
Glaxo Group Ltd |
Fusiones y conjugados de farmaco.
|
|
US20110223149A1
(en)
|
2009-10-14 |
2011-09-15 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
EP2512518A1
(en)
|
2009-12-16 |
2012-10-24 |
Novo Nordisk A/S |
Glp-1 receptor agonist compounds with a modified n-terminus
|
|
US8703701B2
(en)
|
2009-12-18 |
2014-04-22 |
Indiana University Research And Technology Corporation |
Glucagon/GLP-1 receptor co-agonists
|
|
US20110243943A1
(en)
|
2010-04-02 |
2011-10-06 |
Athena Discovery, Inc. |
Treatment using relaxin-fusion proteins with extended in vivo half-lives
|
|
JP2013532172A
(ja)
*
|
2010-07-09 |
2013-08-15 |
ダナ ファーバー キャンサー インスティテュート インコーポレイテッド |
安定化したインスリン分泌促進ペプチド及び使用方法
|
|
BR112013000603A2
(pt)
|
2010-07-09 |
2016-07-05 |
Jv Bio Srl |
anticorpos conjugados com lipídios
|
|
WO2012012352A2
(en)
|
2010-07-19 |
2012-01-26 |
Amidebio, Llc |
Modified peptides and proteins
|
|
KR101382593B1
(ko)
|
2010-07-21 |
2014-04-10 |
한미사이언스 주식회사 |
신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물
|
|
MA34521B1
(fr)
|
2010-08-17 |
2013-09-02 |
Ambrx Inc |
Polypeptides de relaxine modifiés et leurs utilisations
|
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
|
US9029332B2
(en)
|
2010-12-15 |
2015-05-12 |
The Research Foundation For The State University Of New York |
Cross-linked peptides and proteins, methods of making same, and uses thereof
|
|
US8507428B2
(en)
|
2010-12-22 |
2013-08-13 |
Indiana University Research And Technology Corporation |
Glucagon analogs exhibiting GIP receptor activity
|
|
SG191252A1
(en)
|
2010-12-22 |
2013-07-31 |
Marcadia Biotech Inc |
Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
|
|
CA2834657A1
(en)
|
2011-04-29 |
2012-11-01 |
Kinemed, Inc. |
Chemical modification of apolipoprotein mimetic peptides for the production of therapeutic agents
|
|
EP2726502A1
(en)
|
2011-07-01 |
2014-05-07 |
Bayer Intellectual Property GmbH |
Relaxin fusion polypeptides and uses thereof
|
|
JP2014529293A
(ja)
|
2011-07-08 |
2014-11-06 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ |
レラキシンを放出する融合タンパク質およびその使用
|
|
AR088392A1
(es)
|
2011-10-18 |
2014-05-28 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos
|
|
KR101895047B1
(ko)
|
2011-12-30 |
2018-09-06 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체
|
|
HK1205454A1
(en)
|
2012-02-15 |
2015-12-18 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
CN117462693A
(zh)
|
2012-02-27 |
2024-01-30 |
阿穆尼克斯运营公司 |
Xten缀合组合物和制造其的方法
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9273093B2
(en)
|
2012-10-11 |
2016-03-01 |
Protagonist Therapeutics, Inc. |
α4β7 peptide dimer antagonists
|
|
BR112015009470A2
(pt)
|
2012-11-01 |
2019-12-17 |
Aileron Therapeutics Inc |
aminoácidos dissubstituídos e seus métodos de preparação e uso
|
|
SG11201508469YA
(en)
*
|
2013-05-02 |
2015-11-27 |
Glaxosmithkline Ip Dev Ltd |
Therapeutic peptides
|
|
EP3019531A4
(en)
|
2013-07-11 |
2017-03-15 |
The California Institute for Biomedical Research |
Immunoglobulin fusion proteins and compositions thereof
|
|
CN105792851B
(zh)
*
|
2013-09-13 |
2023-10-10 |
斯克利普斯研究所 |
修饰的治疗剂及其组合物
|
|
AU2014364589B2
(en)
*
|
2013-12-18 |
2020-02-27 |
The California Institute For Biomedical Research |
Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
|
|
US20180228907A1
(en)
|
2014-04-14 |
2018-08-16 |
Arvinas, Inc. |
Cereblon ligands and bifunctional compounds comprising the same
|
|
JO3575B1
(ar)
|
2015-01-09 |
2020-07-05 |
Lilly Co Eli |
مركبات مساعد مشترك من gip وglp-1
|
|
MA41794A
(fr)
|
2015-03-18 |
2018-01-23 |
The California Institute For Biomedical Res |
Agents thérapeutiques modifiés et compositions associées
|
|
WO2016205488A1
(en)
|
2015-06-17 |
2016-12-22 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
|
WO2017007612A1
(en)
|
2015-07-07 |
2017-01-12 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
WO2017024318A1
(en)
|
2015-08-06 |
2017-02-09 |
Dana-Farber Cancer Institute, Inc. |
Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses
|
|
WO2017024317A2
(en)
|
2015-08-06 |
2017-02-09 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
US9809603B1
(en)
|
2015-08-18 |
2017-11-07 |
Deuterx, Llc |
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
|
|
WO2017210600A1
(en)
|
2016-06-03 |
2017-12-07 |
The Scripps Research Institute |
Compositions and methods of modulating immune response
|
|
JOP20190095A1
(ar)
*
|
2016-10-27 |
2019-04-28 |
Janssen Pharmaceutica Nv |
مركبات ببتيد تيروسين-تيروسين الحلقية كمعدلات لمستقبلات الببتيد العصبي y
|
|
CN117510491A
(zh)
|
2016-12-23 |
2024-02-06 |
阿尔维纳斯运营股份有限公司 |
用于迅速加速性纤维肉瘤多肽的靶向降解的化合物和方法
|
|
EP3580212A4
(en)
|
2017-02-08 |
2021-03-17 |
Dana Farber Cancer Institute, Inc. |
REGULATION OF CHEMERIC ANTIGEN RECEPTORS
|
|
AU2018219292B2
(en)
|
2017-02-08 |
2024-09-26 |
Dana-Farber Cancer Institute, Inc. |
Tunable endogenous protein degradation with heterobifunctional compounds
|
|
AU2018248417A1
(en)
|
2017-04-05 |
2019-11-14 |
Revolution Medicines, Inc. |
Compounds that participate in cooperative binding and uses thereof
|
|
US11802132B2
(en)
|
2018-02-23 |
2023-10-31 |
Dana-Farber Cancer Institute, Inc. |
Small molecules for inducing selective protein degradation and uses thereof
|
|
WO2019203645A1
(en)
*
|
2018-04-19 |
2019-10-24 |
Stichting Vu |
Protein macrocyclization
|
|
TWI847981B
(zh)
*
|
2018-04-25 |
2024-07-11 |
比利時商健生藥品公司 |
類升糖素肽1 (glp-1)融合肽偶合環狀酪酪肽接合物及其用途
|
|
CN112469731B
(zh)
|
2018-07-23 |
2024-11-29 |
伊莱利利公司 |
Gip/glp1共激动剂化合物
|
|
EP3864030A4
(en)
|
2018-10-12 |
2022-09-21 |
The Scripps Research Institute |
Compounds and methods for dcaf-mediated protein degradation
|
|
AU2020397917A1
(en)
*
|
2019-12-04 |
2022-06-23 |
The Scripps Research Institute |
GLP2 receptor agonists and methods of use
|
|
MX2023014771A
(es)
|
2021-06-09 |
2024-03-19 |
Scripps Research Inst |
Conjugados peptidicos duales gip/glp-1 de accion prolongada y metodos de uso.
|